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Abstract
Background: Guidelines for colorectal cancer screening recommend that patients be informed about options and
be able to select preferred method of screening; however, there are no existing measures available to assess
whether this happens.
Methods: Colorectal Cancer Screening Decision Quality Instrument (CRC-DQI) includes knowledge items and
patients' goals and concerns. Items were generated through literature review and qualitative work with patients
and providers. Hypotheses relating to the acceptability, feasibility, discriminant validity and retest reliability of the
survey were examined using data from three studies: (1) 2X2 randomized study of participants recruited online, (2)
cross-sectional sample of patients recruited in community health clinics, and (3) cross-sectional sample of providers
recruited from American Medical Association Master file.
Results: 338 participants were recruited online, 94 participants were recruited from community health centers, and
115 physicians were recruited. The CRC-DQI was feasible and acceptable with low missing data and high response
rates for both online and paper-based administrations. The knowledge score was able to discriminate between
those who had seen a decision aid or not (84% vs. 64%, p <0.001) and between providers, online patients and clinic
patients (89% vs. 74% vs. 41%, p <0.001 for all comparisons). The knowledge score and most of the goals had
adequate retest reliability. About half of the participants received a test that matched their goals (47% and 51% in
online and clinic samples respectively). Many respondents who had never been screened had goals that indicated a
preference for colonoscopy. A minority of respondents in the online (21%) and in clinic (2%) samples were both
well informed and received a test that matched their goals.
Conclusions: The CRC-DQI demonstrated good psychometric properties in diverse samples, and across different
modes of administration. Few respondents made high quality decisions about colon cancer screening.
Keywords: Colon cancer screening, Decision quality, Shared decision making, Quality measurement, Survey
research, Psychometrics
Background
Clinical guidelines strongly recommend that adults age
50–75 be screened for colorectal cancer (CRC); however,
guidelines also recognize that there are multiple screening
options available [1]. A high quality decision in situations
where there is more than one reasonable option requires
ensuring that patients are informed, and that the choice of
test reflects patients’goals and concerns [2,3].
Several studies have examined the extent to which
patients are informed and engaged in the decision about
CRC screening. Patients have been shown to have
significant knowledge gaps about screening, and lack un-
derstanding of common terms relating to colon cancer
[4-6]. Studies have also identified several factors that are
important to patients when considering what kind of test
to have, such as reducing chance of dying of colon cancer,
the invasiveness of the test, and test preparation [5,7].
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ledge and different methods of assessing patients’ goals.
There is a need for a comprehensive measure of decision
quality that can assess whether patients are informed and
receive screening tests that match their goals.
Sepucha and colleagues have developed and tested
decision quality instruments that assess patients’
knowledge, and the extent to which treatments match
their goals for patients facing surgical decisions,
including breast cancer surgery [8-10]. A similar
process was used to develop and evaluate a survey instru-
ment to measure the quality of CRC screening decisions.
This manuscript describes the development process and
results of three studies that evaluated the psychometric
properties (e.g. reliability, validity, and precision) and
clinical sensibility (e.g. interpretability, acceptability, and
feasibility) of the new survey instrument [11].
Methods
Item development
The Colorectal Cancer Screening Decision Quality
Instrument (CRC-DQI) development process followed
principles of survey research methods [12,13]. Nine can-
didate facts and thirteen goals were identified through a
review of the clinical evidence and reports from focus
groups of patients. The facts and goals were then rated on
importance, accuracy and completeness by a convenience
sample of patients (n= 27) and clinical experts (n =16)
including primary care physicians, nurses and gastro-
enterologists. Based on the ratings, new content was
added (e.g. covering how often the tests need to be done,
which tests require sedation) and some content was removed
(e.g. quantitative estimate of disease free survival benefit
from screening). Then, experts in survey research drafted
questions to cover the content and conducted cognitive in-
terviews with men and women (n=6) to evaluate the items.
Revisions to the items, responses and formatting of the sur-
vey were made to improve acceptability and comprehension.
The resulting instrument was then tested in three samples.
Study sample and procedures
Study 1: online sample
Patients were recruited through Craig’s List Internet ads in
8 U.S. cities. All respondents were screened for eligibility by
a member of the study staff. Eligible respondents were
adults 35–70 years of age who did not have a prior diagno-
sis of colon cancer. Younger participants (aged 35–49) were
included in order to ensure a range of knowledge scores
and adequate sample size for comparisons for the know-
ledge items across the different modes of administration.
Eligible participants were randomized in 2×2 design to
(1) receive a decision aid or not and (2) complete the
survey online or by mail. The decision aid, Colon Cancer
Screening: Deciding What’sR i g h tF o rY o u ,is an 31 minute
DVD and booklet produced by Informed Medical Decisions
Foundation and Health Dialog ©2010. The initial packet
included a cover letter, decision aid (if appropriate), survey
(if appropriate) and incentive. Participants randomized to
complete the survey online received an email with a link
to the survey about 1 week after the cover letter. Non-
respondents received a reminder (via email or mail) two
weeks later. A subset of responders received a retest packet
four weeks later (delivered in the same mode, email or mail,
as the initial survey). A small incentive was provided with
each survey (valued at $30 US for decision aid group, $20
US for no-decision aid group, $20 US for retest).
The study protocol for the online patient survey was
approved by the Partners Human Research Committee,
UMass Boston Institutional Review Board and University
of Virginia Insitutional Review Board for Health Services
Research. Consent was implied byt h ev o l u n t a r yc o m p l e t i o n
of the survey instruments.
Study 2: clinic sample
The online patient sample had very high education levels
and limited diversity, so we recruited a sample of patients
aged 50 and older from community health centers in order
to examine the generalizability of the results. Patients
and family members in the clinics’ waiting rooms were
approached by trained staff and asked if they wanted to
participate in an interview about colorectal cancer screen-
ing. Subjects did not need to have any prior experience with
screening. If participants consented, they were brought to a
separate room to complete a 20 minute interview followed
by the written questionnaire. Staff members were trained to
administer the written survey orally if the participant asked
for help. Subjects were compensated $20 for participating
in the interview and completing the questionnaire. The
protocol was approved by the Institutional Review Boards
at all participating sites.
Study 3: provider survey
We identified primary care physicians and specialists
through the American Medical Association Master File
from 17 cities in the United States (including the 8 cities
where patients were recruited for the online study). For the
colon cancer screening sample, we selected 200 physicians
across internal medicine (n=100) and gastroenterology
(n=100). Each provider was mailed a study packet with a
$20 US cash incentive. A phone reminder was made at
two weeks and a mailed reminder was sent at four weeks.
The study protocol for the providers was approved by the
Institutional Review Board and provider consent was
implied by the voluntary completion of the survey.
Measures
Patients completed demographics, screening history and
the following measures.
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Instrument). 16 multiple choice knowledge items and 10
goals and concerns rated on an importance scale from 0
(not at all important) to 10 (extremely important). The
items used in the field test are available as Additional file 1.
Top Three Goals and Concerns: Patients indicated the
top three goals and concerns that were most important
to their decision.
Involvement in Decision Making: assessed with two
items (1) who made the decision about testing and (2)
how much they were involved in the decision.
Providers completed the full set of CRC-DQI knowledge
items and were asked to rate the knowledge items overall
and individually for how well they covered information
that is essential for patients to know.
Statistical Analysis
Sample Size: 150 participants in each group would allow
us to detect a clinically meaningful difference in knowledge
between decision aid and control groups of 10% with 90%
power (assuming common standard deviation of 20%) and
a difference in mode (online vs. mail) on response rates
a n do nm i s s i n gd a t ao f2 %( a s s u m i n gc o m m o ns t a n d a r d
deviation of 0.5%) with 80% power.
Item Retention and Deletion: A group of experts in
survey research, decision sciences and clinical experts
examined responses for issues such as difficulty (e.g.,
too easy or too hard), problematic format (e.g., multiple
responses checked off when only one was expected),
redundancy (high inter-item correlation), and floor or
ceiling effects (responses bunched at bottom or top of
the scale). Problematic items were deleted or recom-
mended for revision.
DQI- Knowledge Score: Each correct response received
one point. Missing responses were considered incorrect
and a total knowledge score was calculated for those
who completed at least half of the items. A total know-
ledge score was standardized by dividing the number of
correct responses by the number of items, resulting in
scores from 0% to 100%.
DQI-Concordance Score: Respondents aged 50 and
older who had a screening test were included in these
analyses and were categorized by their screening history
into ‘colonoscopy’ and ‘other test’ groups. Patients who
had never had a screening test were not included in the
regression model and for the purposes of the concor-
dance score, they were not considered to have had a test
that matched their goals. A logistic regression model,
with testing group (colonoscopy vs. other test) as the
dependent variable and the goals as independent variables,
generated a predicted probability of having a colonoscopy.
Patients with a model predicted probability of colonos-
copy >0.5 and who had a colonoscopy or those with a pre-
dicted probability of colonoscopy ≤0.5 and who had some
other test, were classified as a “match.” This yielded a
summary concordance score that indicated the percentage
of patients whose screening decisions “matched” their goals.
Higher concordance scores indicate that more participants
received screening tests that matched their goals.
Decision Quality Indicator: A binary variable was
created that was “1” for patients who were both well-
informed (i.e. knowledge score at or above the mean
knowledge score of the decision aid group) and had a
test that matched their goals, indicating high decision
quality, and “0” otherwise.
Acceptability and Feasibility: Acceptability was exa-
mined using the response rates. Feasibility was examined
using rates of missing data.
Reliability: Test-retest reliability was assessed by
calculating the intraclass correlation coefficient (ICC)
for the total knowledge score and for the individual
goals and concerns. The target was to exceed 0.7 [14].
Internal consistency for thek n o w l e d g es c o r ew a sn o t
calculated as the set of knowledge items is not a measure
of one underlying construct.
There is no gold standard for measuring knowledge or
concordance so the following hypotheses were used to
examine the validity of the scores:
Discriminant Validity: A key feature of a knowledge
test is that it can discriminate among those with diffe-
rent levels of knowledge. Two hypotheses were exa-
mined (a) mean knowledge scores would be higher for
providers than patients (two sample t-test) and (b) the
decision aid group would have higher knowledge than
the control group (two sample t-test).
Construct Validity: The hypothesis that patients who are
more involved in decision making should be more likely
to have high decision quality was examined using Fisher’s
exact test to compare the percentages across groups.
Mode Effect: Differences in response rates and rates of
missing items by mode (online versus mail) were compared.
Brief version
A short version of the instrument, with five knowledge
items, was created and evaluated for reproducibility, retest
reliability and discriminant validity.
Analyses were conducted using PASW Statistics 18.0.
Results
Response rates and sample
For the online sample, 338/367 (92%) participants responded
to the initial survey and 71/84 (84.5%) responded to the re-
test survey. The decision aid and no decision aid arms were
balanced on all demographic characteristics. For the clinic
sample, 94 participants were enrolled (data regarding
response rate was not available). Participant characte-
ristics for these two samples are in Table 1. For the provider
sample, 115/193 (59.6%) responded and their characteristics
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were slightly younger than responders (51 vs. 53 years old,
p=0.04), but did not differ by gender or specialty.
Item retention and deletion
Six knowledge itemsw e r ei d e n t i f i e da sb e i n gt o oe a s y
(i.e., patient scores were >85%). Four of them were
removed because the provider importance scores were
also low and two were revised to be included in the
future version of the instrument. Across both patient
samples, total knowledge scores ranged from 10-100%
with no evidence of a floor or ceiling effect.
Responses for the goals ranged across the entire set of
options, though three of the goals had evidence of a ceil-
ing effect. Many respondents selected 10 out of 10 for
“to know whether or not you have colon cancer” (64%),
“to try to find colon cancer or polyps early” (57%), and “to
avoid a test that can cause bleeding or a tear in the colon”
(56%). These three items were kept in for analyses because
they also had the highest percentage of patients who indi-
cated that each goal was one of their top three issues. Two
goals were eliminated as few patients included them as
one of their top three goals: “avoid a test where you have
to drink a liquid before the test to clean out your colon
(6% selected this item), and “avoid a test that requires you
to handle your stool” (only 5% selected this item).
The remaining analyses were conducted using a reduced
set of 10 knowledge items and the 8 goals and concerns.
Acceptability and feasibility
The survey had a high response rate 338/367 (92%) and
few missing items (1.3% for knowledge items and 0.7%
for goals on average) for the online patient sample.
Missing items did vary by mode of administration for
knowledge (2.5% vs. 0.2%, p< 0.001 for paper and online
versions respectively) but did not vary by mode for the
Table 1 Patient demographics for the online and in-clinic samples
Online Clinic
sample Sample
Total DA No DA Total
Characteristic*, ** N=338 N=163 N=175 N=94
Female (%) 229 (68%) 107 (66%) 122 (70%) 38 (40%)
Age mean (SD) 48.9 (9.0) 49.0 (9.1) 48.5 (9.2) 59.6 (8.3)
Hispanic (%) 34 (10%) 15 (9%) 19 (11%) 0 (0%)
Race (%)
White 289 (85.5%) 140 (86%) 149 (85%) 47 (50%)
Black 31 (9%) 17 (10.4%) 14 (8%) 44 (47%)
Other race 19 (6%) 8 (5%) 11 (6%) 3 (3%)
Education (%)
≥ College graduate 193 (57%) 97 (59.5%) 96 (55%) 9 (10%)
Some college 114 (34%) 50 (31%) 64 (37%) 25 (27%)
High school or less 31 (9%) 16 (10%) 15 (9%) 59 (63%)
Screening History (For respondents 50 and older) N=150 N=80 N= 68 N=94
Never tested 53 (35%) 34 (43%) 19 (27%) 29 (31%)
Colonscopy 68 (45%) 35 (44%) 33 (47%) 54 (57%)
Other test only 29 (19%) 11 (14%) 18 (26%) 8 (9%)
DA= Decision aid.
*There were no significant differences on any of these factors between DA and no DA arms, p> 0.05.
**Percentages might not add up 100% due to rounding or missing data.
Table 2 Provider demographics
N= 115
Gender (Male) 85 (74%)
Age mean (SD) 53 (9)
# of Years in Practice 22 (SD 9.6)
Mean (SD)
Annual patient volume Median (IQ) 1,000 (Q1: 450; Q3: 1,100)
Hispanic (%) 6 (5%)
Race (%)
White 78 (68%)
Black 6 (5%)
Asian 25 (22%)
Other race 3 (3%)
Professional Training (%)
Primary care physician 56 (49%)
Gastroenterologist 58 (50%)
Nurse practitioner 1 (1%)
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but overall the amount was still low, 3.2% (range 1.2-7.4%)
for knowledge items and 4.0% (range 1.1 – 5.3%) for goal
items. None of the online respondents and only one
r e s p o n d e n ti nt h ec l i n i cs a m p l ew a sm i s s i n gm o r et h a n
half of the knowledge items and did not receive a total
knowledge score.
Reliability
The knowledge score had retest reliability ICC =0.67
(95% CI 0.47, 0.79). The retest reliability of three goals
was strong “find colon cancer or polyps early” (ICC=0.87),
“to know whether or not you have colon cancer”
(ICC= 0.85), and “avoid test where a tube is put into your
rectum to look at the colon” (ICC=0.74). Three others
were modest “avoid test that is painful” (ICC=0.68), “to
avoid a test that can cause bleeding or a tear in the colon”
(ICC=0.68), and “choose test that doesn’t cost you a lot
of money” (ICC=0.61). Two had low retest reliability
“chose a test that does not need to be done every year”
(ICC =0.47) and “c h o s eat e s tw h e r ey o ut a k em e d i c i n e
before the test that makes you sleepy” (ICC= 0.55).
Knowledge score
Participants in the decision aid (DA) group had higher
knowledge scores than those in the control, (84% vs. 64%,
p<0.001). This difference remained significant when the
sample was restricted to the population aged 50 and older
(e.g. estimated mean difference 17.5% (95%CI 12.1%,
22.9%), p=0.001 in the DA and non DA groups). Pro-
viders also had significantly higher knowledge scores than
the online sample (88.7% vs. 73.8%, p<0.001). Table 3
shows scores on the individual knowledge items across
the different samples. The clinic sample, none of whom
had viewed a decision aid, had significantly lower mean
knowledge score than the online sample (40.6% vs. 73.8%,
p< 0 . 0 0 1 ) .
The majority of providers (81%) felt that the set of
knowledge items covered the key facts extremely or very
well, supporting content validity. The provider ratings of
whether the individual items were “essential” varied from
17% for “Out of every 100 people, about how many will
die from colon cancer?” to 69% for “At what age do
doctors usually recommend people start getting regular
tests for colon cancer.”
DQI-concordance score
Figure 1 contains the plots of the mean importance
scores on selected goals for patients who reported ha-
ving had a colonoscopy, some other screening test and
never being screened. Three goals, desire to “find colon
cancer or polyps early,”“ know whether or not you have
cancer,” and “avoid a test where a tube is put into your
rectum to look at the colon,” discriminated significantly
between those who had colonoscopy and those who did
not in the online sample (see Figure 1). In multivariable
analysis, two of these goals were associated with having
colonoscopy versus some other test (see Table 4).
Patients who felt it was important to “know whether or
not you had colon cancer” were more likely to have a
colonoscopy and patients who felt it was important to
“avoid a test where a tube is put into rectum to look at
the colon” were less likely to have a colonoscopy. The
concordance score, or number of participants in the
online sample who received a screening test that matched
that predicted by their stated goals was 47.3% (71/150).
The fifty-two respondents who were 50 or older and
who had never been screened in the online sample were
not considered to have received a test that matched their
goals. The majority of them (57%) had goals that
suggested a preference for colonoscopy and 43% had
goals that suggested some other screening test would be
the best fit. In the clinic sample, (35/74) 47.3% had a
screening test that matched their goals. About half the
clinic participants who had never been screened (53.8%)
had goals that suggested a preference for colonoscopy.
Decision quality indicator
In the online sample, 32/151 (21.2%) met the definition
of high decision quality, (i.e. knowledge score at or
above 84%, the mean of the decision aid group, and had
a test that matched their goals). Participants with high
decision quality were less likely to say that the doctor
made the decision compared to those who did not meet
criteria for high decision quality, but the difference was
not significant (29.7% vs. 38.9%, p =0.25 for the online
sample). For the clinic sample, only two repondents met
the threshold for being considered informed, and as a
result, only 3% of respondents met our definition of high
decision quality.
Brief version
A shorter, five item version of the knowledge test had
retest reliability (ICC=0.54) and reproducibility to the
total knowledge score (Pearson R=0.89). The knowledge
scores using the brief version also discriminated between
the DA group and the control (85.4% vs. 58.9%, p <0.001)
and between providers and patients in the online sample
(82.1% vs. 74.3%, p=0.008).
Discussion
The CRC-DQI is a new survey that examines the extent
to which patients are informed and receive tests that
match their goals. High acceptability and feasibility of
the instrument is evidenced by the high response rate
and the low number of missing responses in diverse pa-
tient samples. The survey instrument is acceptable and
feasible when administered online, by mail or in person.
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those who were more or less informed, including pro-
viders and patients, and those who have seen a decision
aid or not. The participants in the decision aid group
and virtually all providers had a good understanding of
the frequency of screening for the different tests and the
likelihood of serious side effects with colonoscopy. Par-
ticipants in the decision aid arm were also more likely to
have realistic expectations for the incidence and lethality
of colon cancer, significantly more accurate than pro-
viders (p<0.001). The overall magnitude of the improve-
ment in knowledge for the decision aid group compared
to the control was more than that seen in the Cochrane
Collaborative systematic review of decision aids [15].
Few patients from the clinic sample, which was a more
diverse and underserved sample, were able to answer the
knowledge items correctly. Other studies have found
knowledge gaps about colon cancer screening, particu-
larly in underserved populations [16,17]. Decision aids,
like the one used in the online sample, have been shown
to increase knowledge and intention to screen, even in
underserved samples [15,18]. It may be more important
to distribute these types of tools to underserved patients
to ensure informed decisions.
There are several screening options available to patients.
Three goals appeared to have strongest association with
screening choice: the desire to find colon cancer early and
to know whether you have cancer appeared to be traded off
with the desire to avoid invasive tests. These three goals
had good retest reliability and were able to discriminate
among those who had colonoscopy versus some other
test. To support shared decision making conversations
around colon cancer testing, it would be important for
providers to assess, at a minimum, how patients feel
about these three issues.
In this study, those who did not get screened were
categorized as not having made a “concordant” deci-
sion. Guidelines clearly support some sort of colon
cancer screening for men and women age 50–75 [1]. It
is certainly possibly that an individual may consider
the potential benefits and harms of colon cancer
screening and make an informed decision not to pur-
sue screening. However, about half of the respondents
who did not report any screening test for each sample,
had goals that indicated a preference for colonoscopy.
The other half were not significantly different from
those who had some other test.
A small percentage in each group met both of the
criteria for a high quality decision, suggesting consi-
derable room for improvement across all samples. The
level of decision quality did not vary by the type of test
(colonoscopy vs. other test). The results from this
study did not find an association between self reported
participation in the decision and decision quality. Studies
have suggested that engaging patients though the use
of decision aids or offering them a choice of screening
Table 3 Correct responses to knowledge items for each sample
Online Providers Clinic
sample Sample
Question (correct answer) DA No DA
N=163 N=175 N=115 (%) N=94 (%)
1. At what age do doctors usually recommend people start getting regular
tests for colon cancer? (50)*
150 (92%) 126 (72%) 114 (99%) 50 (53%)
2. Out of every 100 people about how many will get colon cancer some
time in their lives? (6)*
109 (67) 63 (36%) 66 (57%) 6 (6%)
3. Does having a colon cancer test result that is not normal always mean that
a person has colon cancer? (No)
155 (95%) 168 (96%) 113 (98%) 81 (86%)
4. How often do serious problems, such as serious bleeding or a tear in the
colon, happen as a result of a colonoscopy? (Rarely)*
151 (93%) 125 (71%) 109 (95%) 55 (59%)
5. For a person with an average risk for colon cancer, which test do doctors
recommend be done every year? (Stool blood test)*
140 (86%) 96 (55%) 112 (97%) 28 (30%)
6. For a person with an average risk for colon cancer, which test do doctors
recommend be done every 10 years? (Colonoscopy)*
147 (90%) 115 (66%) 111 (97%) 48 (51%)
7. How does regular testing for colon cancer change the chances that a person
will die from colon cancer? (Decreases chance)
156 (96%) 160 (91%) 113 (98%) 70 (75%)
8. Which colon cancer test is least likely to miss a cancer? (Colonoscopy)* 92 (56%) 72 (41%) 100 (87%) 21 (22%)
9. If the results of a colon cancer test are normal, is it possible that a person
could still have colon cancer? (Yes)
136 (83%) 148 (85%) 110 (96%) 71 (76%)
10. Out of every 100 people about how many will die of colon cancer? (3)* 133 (82%) 53 (30) 73 (64%) 12 (13%)
DA= decision aid; *p< 0.05 for DA vs. no DA.
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be important for future studies to examine whether
higher decision quality leads to higher screening rates.
There are several limitations to the studies that should
be noted. The retrospective surveys are subject to recall
bias and the respondents’ knowledge and goals may be
different if assessed closer to the time of the actual de-
cision. The sample recruited online was well educated,
had Internet access and may not generalize to the
wider population. The clinic sample had much more
diversity with respect to race, socioeconomic variables
and education; however, it was limited to English speaking
respondents and we did not have information on clinic
non responders. Further, some of the differences between
the online and clinic samples may be due to differences in
mode of administration (e.g. those completing the survey
o n l i n em a yh a v el o o k e du pi n f o r m a t i o nr e g a r d i n gt h e
Table 4 Multivariate analyses of factors associated with
getting colonoscopy versus other screening test from
online sample
Factor Odds ratio of
Colonoscopy (95%CI)
To know whether or not you have colon cancer 1.83 (1.16, 2.90)
To avoid a test where a tube is put into
your rectum
0.70 (0.56, 0.88)
To avoid a test that can cause bleeding or a
tear in the colon
0.84 (0.58, 1.21)
To try to find colon cancer or polyps early 0.74 (0.48, 1.14)
To choose a test that does not need to be
done every year
1.15 (0.94, 1.40)
To choose a test that doesn’t cost you a lot
of money
0.95 (0.79, 1.14)
To avoid a test that may be painful 1.19 (0.91, 1.55)
Bolded factors were significant in the multivariate model.
Find colon cancer or polyps early To know whether or not you have colon cancer
To have a test that does not cost a lot Avoid test where a tube is put into the rectum
Have a test that does not need to be done every year Avoid a test that can cause bleeding or tears in colon
*
Colonoscopy     Other test     Never Tested Colonoscopy     Other test     Never Tested
Colonoscopy     Other test     Never Tested Colonoscopy     Other test     Never Tested
Colonoscopy     Other test     Never Tested Colonoscopy     Other test     Never Tested
Extremely 
important
Somewhat 
important
Extremely 
important
Somewhat 
important
Extremely 
important
Somewhat 
important
Extremely 
important
Somewhat 
important
Extremely 
important
Somewhat 
important
Somewhat 
important
*p<0.05 for colonoscopy vs. never tested; †p<0.05 for colonoscopy vs. other test for online sample 
‡p<0.05 for colonoscopy vs. never tested; §p<0.05 for colonoscopy vs. other test for clinic sample 
Figure 1 Mean importance scores for selected goals for online and clinic samples based on screening status.
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did not have that opportunity). Despite these limitations,
the studies do provide considerable data to evaluate the
properties of the survey instrument and its use in different
populations, and with different modes of administration.
Conclusions
The CRC-DQI is a new survey instrument that has de-
monstrated strong content validity, discriminant validity
and moderate retest reliability. As guidelines increasingly
emphasize the importance of informing patients and
offering them a choice of screening tests for colon cancer,
the CRC-DQI provides a validated means of measuring
whether that occurs. The survey may be administered
online, by mail, or in person, to evaluate the extent to
which colon cancer screening decisions are informed and
match patients’goals.
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